PROCEPT BioRobotics Q1 revenue up 55% to $69.2M; raises FY2025 guidance to $323M

PROCEPT BioRobotics Corp

2025-Q1 EPS reported -$0.45 revenue$69,162,000

Total revenue $69.2M, +55% YoY; U.S. revenue $60.3M (+50%); international $8.9M (+104%).
U.S. handpiece/consumable revenue $38.0M (+61%); U.S. system/rental $18.7M (+31%).
Sold 43 new U.S. robotic systems; install base 547. Gross margin expanded to 64% from 56%.
Net loss $24.7M (vs $26.0M loss YoY); Adjusted EBITDA loss $15.8M (vs $20.4M loss).
FY2025 revenue guidance raised to $323M (+44% YoY); gross margin ~64.5% with possible $5M tariff headwind.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.